Comments
Lupin on Wednesday said its US-based subsidiary Lupin Pharmaceuticals Inc has launched its generic of Janssen Pharmaceuticals Inc’s contraceptive drug Ortho Tri-Cyclen in the US. Lupin will sell the generic tablets — a combination of norgestimate and ethinyl estradiol — in strengths of 0.18 mg/0.035 mg, 0.215 mg/0.035 mg and 0.25 mg/0.035 mg. According to IMS Health data, Ortho Tri-Cyclen recorded sales of $177.6 million in the US in the year ended March. Shares of Lupin ended 1.25 per cent higher at ₹1,715.15 on the NSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.